Dupixent pricing?

Dupixent (dupilumab) pricing varies a lot by country, insurer, and dose. Here’s a quick US-focused snapshot and what usually matters:

- List price in the US: roughly around $3,000 per month for typical adult dosing. Annual list-price often cited in the ~$36,000–$48,000 range, depending on exact dosing (loading dose and whether you’re on 300 mg every other week vs. a higher loading schedule).
- Your actual out-of-pocket: usually much lower or higher depending on your insurance plan, deductible, and whether you use manufacturer savings programs. Copays can range from $0 up to several thousand dollars per year in some cases.
- Dosing can affect cost: Dupixent dosing varies by indication (atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps) and body weight. The most common adult regimen is a loading dose followed by 300 mg every two weeks, but exact dosing should be confirmed with your doctor.
- Biosimilars/generic: There are no approved generic versions or biosimilars of Dupixent in the US as of now, so price competition from generics is limited.

Ways to potentially lower cost:
- Check with your insurer about coverage and the exact copay or coinsurance.
- Use manufacturer savings programs or patient assistance programs offered by Regeneron/Sanofi. These can reduce out-of-pocket for eligible patients.
- Ask about prior authorization requirements; sometimes getting PA approval can help with coverage and costs.

If you’d like, tell me:
- Are you in the US or another country?
- Do you have insurance (and what kind of plan)?
- Which condition is being treated and what dose has been prescribed?

With that, I can give a more tailored sense of likely out-of-pocket costs and any savings options.